MedTrace Logo

The Efficacy And Cognitive Impairment Of Modified Electroconvulsive Therapy

NCT02066077 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 280

Last updated 2018-04-23

No results posted yet for this study

Summary

1. To determine the influencing factors of modified electroconvulsive therapy (MECT);
2. To determine the influencing factors and reversibility of the cognitive impairment caused by MECT;
3. To determine the duration of efficacy of MECT and its affecting factors.

Conditions

Interventions

DRUG

Etomidate

DRUG

Propofol

DEVICE

Bilateral temporal MECT

DEVICE

The right temporal MECT

DEVICE

Bilateral frontal MECT

Sponsors & Collaborators

  • Tongji Hospital

    collaborator OTHER

  • Huashan Hospital

    collaborator OTHER

  • Shanghai Mental Health Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-01
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02066077 on ClinicalTrials.gov